Bioline Rx Ltd ADR (NASDAQ:BLRX) has a beta value of 1.44 and has seen 76.69 million shares traded in the last trading session. The company, currently valued at $24.40M, closed the last trade at $0.27 per share which meant it gained $0.01 on the day or 7.12% during that session. The BLRX stock price is -485.19% off its 52-week high price of $1.58 and 29.63% above the 52-week low of $0.19. If we look at the company’s 10-day average daily trading volume, we find that it stood at 12.2 million shares traded. The 3-month trading volume is 1.65 million shares.
The consensus among analysts is that Bioline Rx Ltd ADR (BLRX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Bioline Rx Ltd ADR (NASDAQ:BLRX) trade information
Sporting 7.12% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BLRX stock price touched $0.27 or saw a rise of 26.51%. Year-to-date, Bioline Rx Ltd ADR shares have moved 27.94%, while the 5-day performance has seen it change 22.18%. Over the past 30 days, the shares of Bioline Rx Ltd ADR (NASDAQ:BLRX) have changed -2.39%. Short interest in the company has seen 1.06 million shares shorted with days to cover at 2.39.
Bioline Rx Ltd ADR (BLRX) estimates and forecasts
Figures show that Bioline Rx Ltd ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -49.91% over the past 6 months, with this year growth rate of 84.04%, compared to 16.60% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 21.53% over the past 5 years.
BLRX Dividends
Bioline Rx Ltd ADR is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Bioline Rx Ltd ADR (NASDAQ:BLRX)’s Major holders
The top two institutional holders are ALYESKA INVESTMENT GROUP, L.P. with over 1.95 million shares worth more than $1.11 million. As of 2024-06-30, ALYESKA INVESTMENT GROUP, L.P. held 2.6966% of shares outstanding.
The other major institutional holder is CVI HOLDINGS, LLC, with the holding of over 0.82 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.46 million and represent 1.126% of shares outstanding.
